Becton Dickinson Wins FDA Approval For 15-Minute Covid-19 Test
Gilead Licencee Gets Indian Regulatory Approval For Remdesivir Covid-19 Therapy
Emergent Bio Signs Major Manufacturing Deal For J&J's Covid-19 Vaccine
Retractions and controversies over coronavirus research show that the process of science is working as it should
Assessing COVID-19’s Impact on the Biotech Industry
U.S. FDA approves GSK’s HIV drug for patients with limited options
Group testing for coronavirus – called pooled testing – could be the fastest and cheapest way to increase screening nationwide
Novartis Strikes $678M Settlement Agreement With U.S. Authorities
Which drugs and therapies are proven to work, and which ones don't, for COVID-19?
From Parkinson’s to peanut allergy, pandemic puts brakes on new drugs
FDA Sets Bar for COVID-19 Vaccine Approval at 50 Percent Effectiveness
Akero Spikes 42%- And Continues To Rally After-Hours- On New NASH Data
Global Hydroxychloroquine Study To Resume After Positive Trial Results
Global COVID-19 prevention trial of hydroxychloroquine to resume
Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction
Vaxart Oral COVID-19 Vaccine Joins Trump’s “Warp Speed,” Ramps Up Manufacturing Capacity
3 "Strong Buy" Coronavirus Stocks With Massive Upside Potential
Gilead Sets Pricing For Remdesivir Vaccine At $2,340 Per Patient
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Former FDA Chief Warns "Half The Population" Could Catch Coronavirus By Year End: Live Updates
Coronavirus Causes Weaponized 'Tentacles' To Sprout From Infected Cells, Directly Inject Virus Into New Ones
Molecular Partners hopes for COVID-19 rebound after eye drug failure
Vaxart Explodes 96%- And Rallies After-Hours- On Covid-19 Deal
3 Biotech Stocks Under $5 With 100%-Plus Upside Potential
Entos Pharmaceuticals announces selection of lead DNA vaccine candidates for COVID-19
3 Under-the-Radar Penny Stocks Gearing up for Gains
Top Analysts See 100%-Plus Upside Potential in These 3 Penny Stocks
Top Analysts Bet on These 3 Penny Stocks; See 100%-Plus Upside Potential
APT Doubles While Other Biotechs Take Off On Rising New Coronavirus Case Numbers
3 "Strong Buy" Penny Stocks With Triple-Digit Upside Potential